SeraCare Announces Receipt of Additional Notice from NASDAQ
February 16 2006 - 5:00PM
PR Newswire (US)
OCEANSIDE, Calif., Feb. 16 /PRNewswire-FirstCall/ -- SeraCare Life
Sciences, Inc. (NASDAQ:SRLSE), today announced that due to not
filing its Form 10-Q for its fiscal quarter ended December 31,
2005, in a timely manner, in violation of NASDAQ Marketplace Rule
4310(c)(14), it has received an Additional Staff Determination
letter from NASDAQ indicating that this filing delinquency will
serve as an additional deficiency for the NASDAQ Listing
Qualifications Panel (the "Panel") to consider in the context of
the proceedings before the Panel. As previously reported, the
Company requested a hearing before the Panel to review the NASDAQ
staff's original determination to delist the Company's securities
based on the Company not filing its Form 10-K for its fiscal year
ended September 30, 2005, in a timely manner. This hearing was held
on February 2, 2006. NASDAQ has advised the Company that the
delisting of its securities has been stayed, pending a final,
written decision by the Panel. About SeraCare Life Sciences
SeraCare Life Sciences Inc. is a manufacturer and provider of
biological products and services to diagnostic, therapeutic, drug
discovery, and research organizations. The Company's offerings
include plasma-based therapeutic products, diagnostic products and
reagents, cell culture products, specialty plasmas, in vitro
stabilizers, and the SeraCare BioBank(TM), a proprietary database
of medical information and associated blood, plasma, DNA and RNA
samples. Headquartered in Oceanside, CA, SeraCare conducts business
throughout the world, and is traded on the NASDAQ national stock
market under the symbol SRLSE. For additional information about
SeraCare Life Sciences Inc., please visit the Company's web site at
http://www.seracare.com/. DATASOURCE: SeraCare Life Sciences Inc.
CONTACT: Tim Ryan, +1-212-477-9007 x24, The Trout Group, , for
SeraCare Life Sciences, Inc. Web site: http://www.seracare.com/
Copyright
Seracare Life Sciences (NASDAQ:SRLSE)
Historical Stock Chart
From Apr 2024 to May 2024
Seracare Life Sciences (NASDAQ:SRLSE)
Historical Stock Chart
From May 2023 to May 2024